The November 2023 ACC/AHA/ACCP/HRS release suggests early, aggressive rhythm control and provides parameters for pausing or stopping therapies, among other recommendations.
Expanding access to naloxone, sterile syringes, and HIV preexposure prophylaxis can help prevent negative consequences of drug use and reduce inequities in overdose-related morbidity and mortality.
Awareness of a patient’s potential procedures and changes in nutritional intake enables the pharmacist to prevent hypoglycemic events by proactively adjusting the insulin regimen.